期刊文献+

氯沙坦钾氢氯噻嗪治疗老年性高血压疗效观察 被引量:9

Observation of curative effect on Losartan Potassium and Hydrochlorothiazide in the treatment of senile hypertension
下载PDF
导出
摘要 目的观察氯沙坦钾氢氯噻嗪对老年性原发性高血压的治疗疗效。方法 120例老年原发性高血压患者口服氯沙坦钾氢氯噻嗪片(氯沙坦钾50mg,氢氯噻嗪12.5mg)1片,晨服,1d1次,观察2周,随访1个月;观察用药期间血压、血糖、血脂、血尿酸、血钾、肝肾功能以及不良反应。结果患者服用氯沙坦钾氢氯噻嗪片1周后,收缩压和舒张压开始下降,治疗前、后血压值比较,差异有统计学意义(P<0.05),在1、2级高血压患者中、高钠饮食的患者中效果最明显,而且无明显的不良反应发生。结论氯沙坦钾氢氯噻嗪片治疗效果确切,能平稳降低老年人高血压,安全性高,服药简单方便,患者依从性好,不良反应少。 Objective To observe the curative effect of Losartan Potassium and Hydrochlorothiazide in the treatment of senile hypertension. Methods One hundred and twenty elderly patients with essential hypertension were given Losartan Potassium and Hydrochlorothiazide (Losartan Potassium 50 mg, Hydrochlorothiazide 12.5 mg) one pill, once a day, morning intake, once a day, they were observed for two weeks and followed up for a month; the blood pressure, blood glucose, blood lipids, blood uric acid, potassium, liver and kidney function and adverse reactions during the treatment were observed. Results After taking Losartan Potassium and Hydrochlorothiazide for one week, the systolic blood pressure and diastolic blood pressure began to decrease and there was statistically significant difference of the blood pressure before and after treatment (P 〈 0.05). Among the patients with hypertension of grade one and two, the patients with high-sodium diet had the most obvious effects and had no significant adverse reactions. Conclusion Losartan Potassium and Hydrochlorothiazide has an exact curative effect, which can reduce hypertension of elderly patients smoothly, and it is of high security, easy to take, and with good compliance and fewer adverse reactions.
作者 钟茂辉 齐林
出处 《中国当代医药》 2012年第23期76-78,共3页 China Modern Medicine
关键词 老年 高血压 固定配比复方制剂 高钠 Elderly Hypertension Fixed-ratio compound preparations High sodium
  • 相关文献

参考文献6

二级参考文献42

共引文献67

同被引文献99

  • 1刘艳.氯沙坦和氨氯地平对高血压病患者血压、血尿酸的作用比较[J].大连医科大学学报,2006,28(3):222-223. 被引量:2
  • 2刘世任,包景泊,李凤梅,李玉华,崔学军.缬沙坦与福辛普利单独及联合治疗老年高血压病的疗效观察[J].时珍国医国药,2006,17(10):2021-2022. 被引量:2
  • 3操名华.厄贝沙坦联合氢氯噻嗉治疗老年高血压病临床观察[J].健康必读,2013,12 (3): 256.
  • 4Maeda A, Tamura K, Kanaoka T, et al. Combination therapy of angiotensin Ⅱ receptor blocker and calcium channel blocker exerts pleiotropic therapeutic effects in addition to blood pressure lowering: amlodipine and candesartan trial in Yokohama (ACTY) [ J ]. Clin Exp Hypertens, 2012,34(4) : 249-257.
  • 5Pfeffer MA, Swedberg K, Granger CB, et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme [ J ]. Lancet, 2003,362 (9386) : 759- 766.
  • 6Yasuno S, Fujimoto A, Nakagawa Y, et al. Fixed-dose combination therapy of candesartan cilexetil and amlodipine besilate for the treatment of hypertension in Japan [J]. Expert Rev Cardiovasc Ther, 2012 , 10(5) :577-583.
  • 7陶智虎,潘泉.硝苯地平联合卡托普利与厄贝沙坦氢氯噻嗪治疗原发性高血压的疗效比较[J].Zhongguo Linchuang BaojlanZazhi,2011,1(9):176.
  • 8杨灵景,杨春景,杨良机.厄贝沙坦氢氯噻嗪和福辛普利治疗原发性高血压的疗效比较[J].中外女性健康(下半月),2014(12):112—113.
  • 9Reynolds K,Gu D,Muntner P,et al. Geographic variations in the prevalence awareness, treatment and control of hypertension in China[J]. J Hypertens,2003,21(7) : 1273-1281.
  • 10Naka T, Vubo K, Nishi K, et al. Angiotension 1[type 1 receptor antagonists candesartan cilexetil EJ~-Yakugaku Zassh, 2013,120 : 1261-1275.

引证文献9

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部